Aeriant Therapeutics AB
PrivateCompany Overview
Aeriant Therapeutics AB operates in Healthcare & Life Sciences and is based in Lund. It was founded in 2005.
Aeriant Therapeutics AB is a biotechnology company that develops novel, disease-modifying inhaled therapies for respiratory diseases such as COPD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aeriant Therapeutics AB Comparables
Compare Aeriant Therapeutics AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arcede Pharma | 96% | |
| Aer Therapeutics | 78% | |
| Merck & Co., Inc. | 77% |
For institutional investors. Book with your work email.
Aeriant Therapeutics AB Funding Rounds
Historical fundraising activity
Aeriant Therapeutics AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aeriant Therapeutics AB's valuation, stock price, and market status.
Is Aeriant Therapeutics AB a public or private company?
Aeriant Therapeutics AB is a private company.
What is the current stock price of Aeriant Therapeutics AB?
Aeriant Therapeutics AB is a private company, so its shares have no public market price. Caplight tracks Aeriant Therapeutics AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aeriant Therapeutics AB worth (valuation)?
Valuation information for Aeriant Therapeutics AB is not publicly available.
Can I buy Aeriant Therapeutics AB stock?
Aeriant Therapeutics AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aeriant Therapeutics AB's last funding round?
Funding round information for Aeriant Therapeutics AB is not publicly available.
Who are the main investors in Aeriant Therapeutics AB?
Investor information for Aeriant Therapeutics AB is not publicly disclosed.
Will Aeriant Therapeutics AB IPO soon?
No public IPO plans have been announced for Aeriant Therapeutics AB.
How can I track Aeriant Therapeutics AB secondary market activity?
Caplight tracks bids, offers, and trades in Aeriant Therapeutics AB's shares on secondary markets.